Literature DB >> 25601276

The deubiquitinating enzyme CYLD regulates the differentiation and maturation of thymic medullary epithelial cells.

Sonja Reissig1, Nadine Hövelmeyer1, Yilang Tang1, Debra Weih2, Alexey Nikolaev1, Marc Riemann2, Falk Weih2, Ari Waisman1.   

Abstract

The cross talk between thymocytes and the thymic epithelium is critical for T-cell development and the establishment of central tolerance. Medullary thymic epithelial cells (mTECs) are located in the thymic medulla and mediate the elimination of self-reactive thymocytes, thereby preventing the onset of autoimmunity. Previous studies identified the deubiquitinating enzyme CYLD as a critical regulator of T-cell development by activating proximal T-cell receptor signaling during the transition of double-positive to single-positive thymocytes. Here we evaluated the impact of the naturally occurring short-splice variant of the cyld gene (sCYLD) on the development and maturation of mTECs. We found that thymi of CYLD(ex7/8) mice, solely expressing sCYLD, displayed a reduced number of mature mTECs caused by a developmental block during the transition of immature to mature mTECs. Further, we could demonstrate an impaired negative selection of thymocytes in these mice. Our data demonstrate that inefficient negative selection in the thymus of CYLD(ex7/8) mice result from a defect in mTEC maturation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25601276     DOI: 10.1038/icb.2014.122

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  41 in total

Review 1.  Promiscuous gene expression and central T-cell tolerance: more than meets the eye.

Authors:  Bruno Kyewski; Jens Derbinski; Jörn Gotter; Ludger Klein
Journal:  Trends Immunol       Date:  2002-07       Impact factor: 16.687

Review 2.  Self-representation in the thymus: an extended view.

Authors:  Bruno Kyewski; Jens Derbinski
Journal:  Nat Rev Immunol       Date:  2004-09       Impact factor: 53.106

3.  Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.

Authors:  Cathy Cecilia Srokowski; Joumana Masri; Nadine Hövelmeyer; Anna Katharina Krembel; Christine Tertilt; Dennis Strand; Karsten Mahnke; Ramin Massoumi; Ari Waisman; Hansjörg Schild
Journal:  Blood       Date:  2009-04-02       Impact factor: 22.113

4.  Positive selection of antigen-specific T cells in thymus by restricting MHC molecules.

Authors:  P Kisielow; H S Teh; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  Dependence of self-tolerance on TRAF6-directed development of thymic stroma.

Authors:  Taishin Akiyama; Shiori Maeda; Sayaka Yamane; Kaori Ogino; Michiyuki Kasai; Fumiko Kajiura; Mitsuru Matsumoto; Jun-ichiro Inoue
Journal:  Science       Date:  2005-02-10       Impact factor: 47.728

6.  The tumor suppressor CYLD controls the function of murine regulatory T cells.

Authors:  Sonja Reissig; Nadine Hövelmeyer; Benno Weigmann; Alexei Nikolaev; Bettina Kalt; Thomas F Wunderlich; Matthias Hahn; Marcus F Neurath; Ari Waisman
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

7.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

8.  NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner.

Authors:  Fumiko Kajiura; Shijie Sun; Takashi Nomura; Keisuke Izumi; Tomoo Ueno; Yoshimi Bando; Noriyuki Kuroda; Hongwei Han; Yi Li; Akemi Matsushima; Yousuke Takahama; Shimon Sakaguchi; Tasuku Mitani; Mitsuru Matsumoto
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

9.  The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator.

Authors:  Yu Hikosaka; Takeshi Nitta; Izumi Ohigashi; Kouta Yano; Naozumi Ishimaru; Yoshio Hayashi; Mitsuru Matsumoto; Koichi Matsuo; Josef M Penninger; Hiroshi Takayanagi; Yoshifumi Yokota; Hisakata Yamada; Yasunobu Yoshikai; Jun-Ichiro Inoue; Taishin Akiyama; Yousuke Takahama
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

10.  An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis.

Authors:  T Hettmann; J DiDonato; M Karin; J M Leiden
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  6 in total

1.  The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.

Authors:  Yan-Xiao Ji; Zan Huang; Xia Yang; Xiaozhan Wang; Ling-Ping Zhao; Pi-Xiao Wang; Xiao-Jing Zhang; Michele Alves-Bezerra; Lin Cai; Peng Zhang; Yue-Xin Lu; Lan Bai; Mao-Mao Gao; Huan Zhao; Song Tian; Yong Wang; Zhi-Xiang Huang; Xue-Yong Zhu; Yan Zhang; Jun Gong; Zhi-Gang She; Feng Li; David E Cohen; Hongliang Li
Journal:  Nat Med       Date:  2018-01-01       Impact factor: 53.440

Review 2.  CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.

Authors:  Marie Lork; Kelly Verhelst; Rudi Beyaert
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

Review 3.  Nuclear Factor-kappaB in Autoimmunity: Man and Mouse.

Authors:  Bahar Miraghazadeh; Matthew C Cook
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 4.  Deubiquitinases as pivotal regulators of T cell functions.

Authors:  Xiao-Dong Yang; Shao-Cong Sun
Journal:  Front Med       Date:  2018-07-27       Impact factor: 4.592

Review 5.  NF-κB: At the Borders of Autoimmunity and Inflammation.

Authors:  Laura Barnabei; Emmanuel Laplantine; William Mbongo; Frédéric Rieux-Laucat; Robert Weil
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

Review 6.  Protein ubiquitination in T cell development.

Authors:  Ting Zhong; Kang Lei; Xiaoxi Lin; Zhiguo Xie; Shuoming Luo; Zhiguang Zhou; Bin Zhao; Xia Li
Journal:  Front Immunol       Date:  2022-08-04       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.